DEF 14A

Company

Mirum Pharmaceuticals, Inc.

Filed

April 14, 2021

Period of Report

June 4, 2021

Accession Number

0001193125-21-116249

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →